These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17254006)

  • 1. Are current practices in the treatment of children with cerebral palsy research-based?
    Autti-Rämo I; Anttila H; Mäkelä M
    Dev Med Child Neurol; 2007 Feb; 49(2):155-6. PubMed ID: 17254006
    [No Abstract]   [Full Text] [Related]  

  • 2. Why do children with cerebral palsy discontinue therapy with botulinum toxin A?
    Weigl DM; Arbel N
    Dev Med Child Neurol; 2007 Feb; 49(2):159-60. PubMed ID: 17297747
    [No Abstract]   [Full Text] [Related]  

  • 3. Botulinum toxin A in cerebral palsy: functional outcomes.
    Graham HK
    J Pediatr; 2000 Sep; 137(3):300-3. PubMed ID: 10969251
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
    Kaishou Xu ; Tiebin Yan ; Jianning Mai
    Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does botulinum toxin prevent or promote deformity in children with cerebral palsy?
    Gough M
    Dev Med Child Neurol; 2009 Feb; 51(2):89-90. PubMed ID: 19191839
    [No Abstract]   [Full Text] [Related]  

  • 6. Botulinum toxin A injection for children with spastic cerebral palsy.
    YaJie W; BaoQin G
    Dev Med Child Neurol; 2008 Aug; 50(8):640. PubMed ID: 18754907
    [No Abstract]   [Full Text] [Related]  

  • 7. 'Why do children with cerebral palsy discontinue therapy with botulinum toxin A?'.
    Linder-Lucht M; Kirschner J; Herrmann J; Geth K; Korinthenberg R; Berweck S; Heinen F; Mall V
    Dev Med Child Neurol; 2006 Apr; 48(4):319-20. PubMed ID: 16542523
    [No Abstract]   [Full Text] [Related]  

  • 8. The expanding role of botulinum toxin type A injections in the management of children with cerebral palsy.
    Carr LJ
    Dev Med Child Neurol; 2009 Sep; 51(9):687-8. PubMed ID: 19709139
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of botulinum toxin type A in children with cerebral palsy.
    Nolan KW; Cole LL; Liptak GS
    Phys Ther; 2006 Apr; 86(4):573-84. PubMed ID: 16579673
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of lateralisation and subluxation of the hip in cerebral palsy with Botulinum toxin A: preliminary results based on the analysis of migration percentage data.
    Placzek R; Deuretzbacher G; Meiss AL
    Neuropediatrics; 2004 Feb; 35(1):6-9. PubMed ID: 15002046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin and cerebral palsy: time for reflection?
    Kerr Graham H; Rodda JM
    Dev Med Child Neurol; 2006 May; 48(5):399. PubMed ID: 16608552
    [No Abstract]   [Full Text] [Related]  

  • 12. [Botulinum toxin in infantile cerebral palsy].
    Póo P; Galván-Manso M; Casartelli MJ; López-Casas J; Gassió-Subirats RM; Blanco C; Terricabras-Carol L
    Rev Neurol; 2008; 47 Suppl 1():S21-4. PubMed ID: 18767013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter to the editor on 'Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials'.
    Idrovo AJ; Albavera-Hernández C; Rodríguez JM
    Clin Rehabil; 2009 Sep; 23(9):862-3. PubMed ID: 19713401
    [No Abstract]   [Full Text] [Related]  

  • 14. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
    Lundy CT; Doherty GM; Fairhurst CB
    Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
    Dai AI; Wasay M; Awan S
    J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum neurotoxin A: an unusual systemic effect.
    Howell K; Selber P; Graham HK; Reddihough D
    J Paediatr Child Health; 2007 Jun; 43(6):499-501. PubMed ID: 17535186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin A in the management of focal muscle overactivity in children with cerebral palsy.
    Gibson N; Graham HK; Love S
    Disabil Rehabil; 2007 Dec; 29(23):1813-22. PubMed ID: 18033606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Botulinum toxin: a new dimension for spasticity].
    Reichel G
    MMW Fortschr Med; 2007 May; 149 Suppl 2():65-9. PubMed ID: 17724971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of sedation using nitrous oxide compared with enteral midazolam for botulinum toxin A injections in children.
    Kumar R; Sneade C; Littler K
    Dev Med Child Neurol; 2009 Oct; 51(10):838-9. PubMed ID: 19747281
    [No Abstract]   [Full Text] [Related]  

  • 20. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
    Crowner BE; Racette BA
    Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.